New study out on Congenital Talipes Equinovarus (CTEV) relapse determinants!
Based on 1,963 clubfeet, the pooled relapse rate is 20.9%. Initial deformity severity and brace non-compliance are the leading predictors.
🔎Read here: shorturl.at/l5leg
#Orthopaedic #PediatricHealth #clubfoot
Based on 1,963 clubfeet, the pooled relapse rate is 20.9%. Initial deformity severity and brace non-compliance are the leading predictors.
🔎Read here: shorturl.at/l5leg
#Orthopaedic #PediatricHealth #clubfoot
September 30, 2026 at 6:42 AM
New study out on Congenital Talipes Equinovarus (CTEV) relapse determinants!
Based on 1,963 clubfeet, the pooled relapse rate is 20.9%. Initial deformity severity and brace non-compliance are the leading predictors.
🔎Read here: shorturl.at/l5leg
#Orthopaedic #PediatricHealth #clubfoot
Based on 1,963 clubfeet, the pooled relapse rate is 20.9%. Initial deformity severity and brace non-compliance are the leading predictors.
🔎Read here: shorturl.at/l5leg
#Orthopaedic #PediatricHealth #clubfoot
📊 Stock movers right now:
BTAI: $0.04 (-27.5%)
VOYG: $30.70 (-18.2%)
APMD: $22.04 (-13.6%)
VOR: $19.20 (-12.7%)
CTEV: $25.86 (-12.2%)
More: https://suggestionbox.live/planet-markets
BTAI: $0.04 (-27.5%)
VOYG: $30.70 (-18.2%)
APMD: $22.04 (-13.6%)
VOR: $19.20 (-12.7%)
CTEV: $25.86 (-12.2%)
More: https://suggestionbox.live/planet-markets
September 23, 2026 at 7:00 PM
📊 Stock movers right now:
BTAI: $0.04 (-27.5%)
VOYG: $30.70 (-18.2%)
APMD: $22.04 (-13.6%)
VOR: $19.20 (-12.7%)
CTEV: $25.86 (-12.2%)
More: https://suggestionbox.live/planet-markets
BTAI: $0.04 (-27.5%)
VOYG: $30.70 (-18.2%)
APMD: $22.04 (-13.6%)
VOR: $19.20 (-12.7%)
CTEV: $25.86 (-12.2%)
More: https://suggestionbox.live/planet-markets
🚨 $CTEV
Garis Douglas Michael (EVP&CFO) sold 9,025 shares at an average price of $30.5900 per common share. (Date: 2026-09-21)
Garis Douglas Michael (EVP&CFO) sold 9,025 shares at an average price of $30.5900 per common share. (Date: 2026-09-21)
SEC Filing: CTEV
Click to view the official SEC document.
www.sec.gov
September 22, 2026 at 8:49 PM
🚨 $CTEV
Garis Douglas Michael (EVP&CFO) sold 9,025 shares at an average price of $30.5900 per common share. (Date: 2026-09-21)
Garis Douglas Michael (EVP&CFO) sold 9,025 shares at an average price of $30.5900 per common share. (Date: 2026-09-21)
#CTEV Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
https://www.stocktitan.net/news/CTEV/claritev-selected-by-gdit-to-support-cdc-s-world-trade-center-health-x2w2kuwxa852.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTEV/claritev-selected-by-gdit-to-support-cdc-s-world-trade-center-health-x2w2kuwxa852.html?utm_source=stocktitan-bluesky&utm_medium=social
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 22, 2026 at 1:00 PM
#CTEV Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
https://www.stocktitan.net/news/CTEV/claritev-selected-by-gdit-to-support-cdc-s-world-trade-center-health-x2w2kuwxa852.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTEV/claritev-selected-by-gdit-to-support-cdc-s-world-trade-center-health-x2w2kuwxa852.html?utm_source=stocktitan-bluesky&utm_medium=social
🚨 $CTEV
Douglas Garis, a Officer, filed a notice of intent to sell 9,025 shares of common stock, valued at approximately $278,060.25, on 09/21/2026.
Douglas Garis, a Officer, filed a notice of intent to sell 9,025 shares of common stock, valued at approximately $278,060.25, on 09/21/2026.
SEC Filing: CTEV
Click to view the official SEC document.
www.sec.gov
September 21, 2026 at 8:35 PM
🚨 $CTEV
Douglas Garis, a Officer, filed a notice of intent to sell 9,025 shares of common stock, valued at approximately $278,060.25, on 09/21/2026.
Douglas Garis, a Officer, filed a notice of intent to sell 9,025 shares of common stock, valued at approximately $278,060.25, on 09/21/2026.
#CTEV Claritev Releases 2025 Corporate Responsibility Report
https://www.stocktitan.net/news/CTEV/claritev-releases-2025-corporate-responsibility-kmd93o4k14kp.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTEV/claritev-releases-2025-corporate-responsibility-kmd93o4k14kp.html?utm_source=stocktitan-bluesky&utm_medium=social
Claritev Releases 2025 Corporate Responsibility Report
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 17, 2026 at 1:00 PM
#CTEV Claritev Releases 2025 Corporate Responsibility Report
https://www.stocktitan.net/news/CTEV/claritev-releases-2025-corporate-responsibility-kmd93o4k14kp.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTEV/claritev-releases-2025-corporate-responsibility-kmd93o4k14kp.html?utm_source=stocktitan-bluesky&utm_medium=social
$CTEV — Officer Change
Claritev Corp (CTEV) appointed Ben Letham, a research scientist at Meta and AI/optimization expert, to its Board of Directors effective September 14, 2026, filling a vacancy. Letham brings deep expertise in AI, large-scale experimentation, and applied data a...
🧵 continued ↓
Claritev Corp (CTEV) appointed Ben Letham, a research scientist at Meta and AI/optimization expert, to its Board of Directors effective September 14, 2026, filling a vacancy. Letham brings deep expertise in AI, large-scale experimentation, and applied data a...
🧵 continued ↓
September 15, 2026 at 4:46 PM
$CTEV — Officer Change
Claritev Corp (CTEV) appointed Ben Letham, a research scientist at Meta and AI/optimization expert, to its Board of Directors effective September 14, 2026, filling a vacancy. Letham brings deep expertise in AI, large-scale experimentation, and applied data a...
🧵 continued ↓
Claritev Corp (CTEV) appointed Ben Letham, a research scientist at Meta and AI/optimization expert, to its Board of Directors effective September 14, 2026, filling a vacancy. Letham brings deep expertise in AI, large-scale experimentation, and applied data a...
🧵 continued ↓
🚨 $CTEV
On September 15, 2026, the Company issued a press release announcing the appointment of Mr. Letham to the Board.
On September 15, 2026, the Company issued a press release announcing the appointment of Mr. Letham to the Board.
SEC Filing: CTEV
Click to view the official SEC document.
www.sec.gov
September 15, 2026 at 1:08 PM
🚨 $CTEV
On September 15, 2026, the Company issued a press release announcing the appointment of Mr. Letham to the Board.
On September 15, 2026, the Company issued a press release announcing the appointment of Mr. Letham to the Board.
Polda Jateng tangani anak penderita clubfoot lewat program CTEV - https://www.antaranews.com/video/5735449/polda-jateng-tangani-anak-penderita-clubfoot-lewat-program-ctev
Polda Jateng tangani anak penderita clubfoot lewat program CTEV - ANTARA News
ANTARA - Program Polda Jateng Peduli CTEV (Congenital Talipes Equinovarus) melakukan observasi klinis terhadap tujuh anak penderita Clubfoot atau ...
www.antaranews.com
September 10, 2026 at 2:26 PM
Polda Jateng tangani anak penderita clubfoot lewat program CTEV - https://www.antaranews.com/video/5735449/polda-jateng-tangani-anak-penderita-clubfoot-lewat-program-ctev
#CTEV Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
https://www.stocktitan.net/news/CTEV/claritev-cares-helps-rural-patients-get-critical-care-closer-to-0t15p1maz6po.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTEV/claritev-cares-helps-rural-patients-get-critical-care-closer-to-0t15p1maz6po.html?utm_source=stocktitan-bluesky&utm_medium=social
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 10, 2026 at 1:00 PM
#CTEV Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
https://www.stocktitan.net/news/CTEV/claritev-cares-helps-rural-patients-get-critical-care-closer-to-0t15p1maz6po.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTEV/claritev-cares-helps-rural-patients-get-critical-care-closer-to-0t15p1maz6po.html?utm_source=stocktitan-bluesky&utm_medium=social
Polda Jateng lacak 88 anak penderita CTEV pastikan peroleh penanganan - https://www.antaranews.com/berita/5735245/polda-jateng-lacak-88-anak-penderita-ctev-pastikan-peroleh-penanganan
Polda Jateng lacak 88 anak penderita CTEV pastikan peroleh penanganan
Polda Jawa Tengah melacak keberadaan 88 anak dengan kelainan kaki bawaan lahir atau Congenital Talipes Equinovarus (CTEV) di berbagai wilayah di provinsi ini ...
www.antaranews.com
September 10, 2026 at 12:11 PM
Polda Jateng lacak 88 anak penderita CTEV pastikan peroleh penanganan - https://www.antaranews.com/berita/5735245/polda-jateng-lacak-88-anak-penderita-ctev-pastikan-peroleh-penanganan
🧵 1/5 🏥 Claritev Corp. ($CTEV)—INSIDER BUY Alert
President, CEO & Executive Chair Travis Dalton bought 6,450 shares at $38.71 (~$0.25M).
President, CEO & Executive Chair Travis Dalton bought 6,450 shares at $38.71 (~$0.25M).
Insider Buying Week 09-04-26
The goal is to find one high conviction buy a week and you will have made yourself a great return in a mostly diversified portfolio. That’s of course if you want diversification. Or could you load…
insomniachedge.com
September 8, 2026 at 2:38 AM
🧵 1/5 🏥 Claritev Corp. ($CTEV)—INSIDER BUY Alert
President, CEO & Executive Chair Travis Dalton bought 6,450 shares at $38.71 (~$0.25M).
President, CEO & Executive Chair Travis Dalton bought 6,450 shares at $38.71 (~$0.25M).
🟢 #CTEV — Dalton Travis, Pres., CEO & Executive Chair
BOUGHT: 4,500 shares @ $38.81
Total: $175K
Filed Aug 26, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CTEV
#InsiderTrading #CTEV #StockMarket
BOUGHT: 4,500 shares @ $38.81
Total: $175K
Filed Aug 26, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CTEV
#InsiderTrading #CTEV #StockMarket
FormDelta — Insider Trading Alerts
Dalton Travis just bought $175K in CTEV. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
August 31, 2026 at 1:15 PM
🟢 #CTEV — Dalton Travis, Pres., CEO & Executive Chair
BOUGHT: 4,500 shares @ $38.81
Total: $175K
Filed Aug 26, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CTEV
#InsiderTrading #CTEV #StockMarket
BOUGHT: 4,500 shares @ $38.81
Total: $175K
Filed Aug 26, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CTEV
#InsiderTrading #CTEV #StockMarket
📄 #CTEV 10-Q — what changed
MD&A now says: "Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements This item and other sections of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of Section 27A of th
MD&A now says: "Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements This item and other sections of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of Section 27A of th
FormDelta — Insider Trading Alerts
What Claritev Corp changed in their own words, quarter over quarter.
www.formdelta.com
August 31, 2026 at 1:05 PM
📄 #CTEV 10-Q — what changed
MD&A now says: "Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements This item and other sections of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of Section 27A of th
MD&A now says: "Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements This item and other sections of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of Section 27A of th
☕Chen, Zhang et al report ctEV-CLOCK as a tool to characterize circulating tumor-derived #ExtracellularVesicles and demonstrate a pattern of #circadian oscillation, which may be leveraged to design time-synchronized targeted #cancer therapy.
👉https://rdcu.be/fCDTU
www.nature.com/articles/s41...
👉https://rdcu.be/fCDTU
www.nature.com/articles/s41...
Circadian control of circulating tumour-derived extracellular vesicle secretion affects targeted therapy efficacy - Nature Cell Biology
Chen, Zhang and colleagues report ctEV-CLOCK as a tool to characterize circulating tumour-derived extracellular vesicles and demonstrate a pattern of circadian oscillation, which may be leveraged to d...
www.nature.com
August 28, 2026 at 10:17 AM
☕Chen, Zhang et al report ctEV-CLOCK as a tool to characterize circulating tumor-derived #ExtracellularVesicles and demonstrate a pattern of #circadian oscillation, which may be leveraged to design time-synchronized targeted #cancer therapy.
👉https://rdcu.be/fCDTU
www.nature.com/articles/s41...
👉https://rdcu.be/fCDTU
www.nature.com/articles/s41...
Circadian control of circulating tumour-derived extracellular vesicle secretion affects targeted therapy efficacy
->Nature | More on "Circadian rhythms and cancer therapy" at BigEarthData.ai
->Nature | More on "Circadian rhythms and cancer therapy" at BigEarthData.ai
Circadian control of circulating tumour-derived extracellular vesicle secretion affects targeted therapy efficacy
(a) Schematic overview of the ctEV-CLOCK workflow for detecting circulating tumour-derived extracellular vesicles (ctEVs) released during the active (nighttime) phase of circadian rhythm analysis. (b) Surface plasmon resonance (SPR) analysis showing the interaction of homobivalent SYL3C (HoBi-SY), homobivalent SJ3C2 (HoBi-SJ), and biparatopic aptamer (BiPar) with EpCAM protein immobilized on a CM5 sensor chip. Aptamer concentrations (10, 20, 40, 80, 160 and 320 nM) were injected, and binding curves were fitted using a 1:1 Langmuir binding model (solid line). (c) Western blot analysis of calnexin, CD63, TSG101, EpCAM and CD9 in the sEVs derived from 4T1 and EpCAM-knockout (EpCAM-KO) 4T1 cells (20 μg protein per sample). The endoplasmic reticulum protein calnexin was used as a negative control for sEVs. Molecular weights (in kDa) are indicated on the right. (d-g) Confocal microscopy images showing binding of FAM-labeled random sequence (RS), biparatopic aptamer (BiPar), DBCO-RS, and DBCO-BiPar to MGL (w/ metabolic glycan labeling) 4T1 sEVs (d), non-MGL (w/o metabolic glycan labeling) 4T1 sEVs (e), MGL EpCAM-KO 4T1 sEVs (f), and non-MGL EpCAM-KO 4T1 sEVs (g). Latex beads coated with MGL or non-MGL 4T1 sEVs, or their EpCAM-KO counterparts, were first incubated with the indicated sequences and subsequently treated with single-stranded DNA binding protein...
www.nature.com
August 24, 2026 at 8:27 PM
On this day 8 years ago, the Gamescom 2018 gameplay trailer for Jump Force was released. The gameplay trailer can be watched below.
www.youtube.com/watch?v=CTEv...
www.youtube.com/watch?v=CTEv...
JUMP FORCE - GAMESCOM 2018 TRAILER | X1, PS4, PC
YouTube video by Bandai Namco Entertainment America
www.youtube.com
August 22, 2026 at 1:15 AM
On this day 8 years ago, the Gamescom 2018 gameplay trailer for Jump Force was released. The gameplay trailer can be watched below.
www.youtube.com/watch?v=CTEv...
www.youtube.com/watch?v=CTEv...
🚨 $CTEV
Misencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares at an average price of $40.0670 per common share. (Date: 2026-08-14)
Misencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares at an average price of $40.0670 per common share. (Date: 2026-08-14)
SEC Filing: CTEV
Click to view the official SEC document.
www.sec.gov
August 18, 2026 at 10:26 PM
🚨 $CTEV
Misencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares at an average price of $40.0670 per common share. (Date: 2026-08-14)
Misencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares at an average price of $40.0670 per common share. (Date: 2026-08-14)
#CTEV #MRAI Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
https://www.stocktitan.net/news/CTEV/marpai-expands-relationship-with-claritev-to-help-reduce-healthcare-3mx91qqzttso.html
https://www.stocktitan.net/news/CTEV/marpai-expands-relationship-with-claritev-to-help-reduce-healthcare-3mx91qqzttso.html
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Claritev (NYSE: CTEV) announced that Marpai (OTCQX: MRAI) has expanded its relationship with Claritev beyond use of the PHCS Network for out-of-network access to include comprehensive pre- and post-payment integrity solutions across the claims lifecycle.Marpai will adopt additional Claritev services such as Advanced Code Editing, Itemized Bill Review, DRG Validation, Data Mining, Coordination of Benefits, and Specialty Claim Reviews. According to Claritev, these capabilities are expected to help identify millions of dollars in potential savings opportunities for Marpai’s self-funded employer clients and improve claim payment accuracy. The expanded services are expected to be implemented within the next 90 days.
www.stocktitan.net
August 17, 2026 at 1:00 PM
#CTEV #MRAI Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
https://www.stocktitan.net/news/CTEV/marpai-expands-relationship-with-claritev-to-help-reduce-healthcare-3mx91qqzttso.html
https://www.stocktitan.net/news/CTEV/marpai-expands-relationship-with-claritev-to-help-reduce-healthcare-3mx91qqzttso.html
Helping children walk towards a better future! Central Java Police launches free medical treatment for kids with clubfoot (CTEV). 🩺 #Healthcare #Indonesia https://jatimaktual.id/artikel/cegah-kecacatan-permanen-polda-jateng-fasilitasi-pengobatan-gratis-anak-penderita-ctev
August 15, 2026 at 3:05 AM
Helping children walk towards a better future! Central Java Police launches free medical treatment for kids with clubfoot (CTEV). 🩺 #Healthcare #Indonesia https://jatimaktual.id/artikel/cegah-kecacatan-permanen-polda-jateng-fasilitasi-pengobatan-gratis-anak-penderita-ctev
🚨 $CTEV
TIFFANI MISENCIK, a Officer, filed a notice of intent to sell 8,850 shares of common stock, valued at approximately $354,592.07, on 08/14/2026.
TIFFANI MISENCIK, a Officer, filed a notice of intent to sell 8,850 shares of common stock, valued at approximately $354,592.07, on 08/14/2026.
SEC Filing: CTEV
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 10:48 PM
🚨 $CTEV
TIFFANI MISENCIK, a Officer, filed a notice of intent to sell 8,850 shares of common stock, valued at approximately $354,592.07, on 08/14/2026.
TIFFANI MISENCIK, a Officer, filed a notice of intent to sell 8,850 shares of common stock, valued at approximately $354,592.07, on 08/14/2026.